ACADIA Pharmaceuticals Inc
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. Show More...
-
Website https://www.acadia-pharm.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 19.66 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 0.39 -0.44 -0.38 -0.44 -0.95 -1.63 -2.34 -2.36 -1.94 -1.6 -1.58 Dividends USD Payout Ratio % * Shares Mil 39.0 52.0 55.0 86.0 97.0 101.0 116.0 122.0 127.0 147.0 150.0 Book Value Per Share * EUR 0.41 0.18 1.44 2.72 2.04 4.51 2.54 1.36 3.97 3.72 Free Cash Flow Per Share * EUR -0.48 -0.16 -0.29 -0.26 -0.51 -0.98 -1.63 -1.73 -1.12 -1.02 Return on Assets % 34.38 -64.57 -29.64 -25.49 -35.94 -60.09 -69.32 -61.21 -53.03 -35.55 -38.12 Financial Leverage (Average) 1.29 1.37 1.28 1.04 1.05 1.11 1.08 1.15 1.13 1.12 1.17 Return on Equity % 72.43 -85.82 -38.49 -28.41 -37.62 -64.58 -75.58 -67.8 -60.22 -39.93 -45.04 Return on Invested Capital % 71.45 -85.65 -38.55 -28.67 -37.93 -64.7 -76.04 -68.38 -61.18 -40.64 -45.72 Interest Coverage Current Ratio 6.35 5.18 18.25 26.99 20.5 10.0 12.86 7.62 8.83 10.16 7.26 Quick Ratio 6.22 5.04 18.15 26.62 20.43 9.9 12.59 7.34 8.42 9.83 6.98 Debt/Equity 0.010 0.010